General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases

Overview of attention for article published in Frontiers in Aging, September 2024

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,849 followers.

RT @FrontAging: New Research: General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases https://t.co/d6VIwv…

RT @FrontAging: New Research: General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases https://t.co/d6VIwv…

New Research: General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases https://t.co/d6VIwvhMvm #FrontiersIn #Aging

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.